|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 16/22 | (2013.01) | ||
| A61P 27/02 | (2018.01) | ||
| C07K2317/56 | (2013.01) | ||
| A61P 9/00 | (2018.01) | ||
| C07K2317/526 | (2013.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K2317/60 | (2013.01) |
| (11) | Number of the document | 3478717 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17737762.9 |
| Date of filing the European patent application | 2017-07-03 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/066495 |
| Date | 2017-07-03 |
| (87) | Number | WO 2018/007314 |
| Date | 2018-01-11 |
| (30) | Number | Date | Country code |
| 16177746 | 2016-07-04 | EP |
| (72) |
DENGL, Stefan , DE
HUELSMANN, Peter Michael , DE
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | NOVEL ANTIBODY FORMAT |
| NOVEL ANTIBODY FORMAT |